Примери за използване на Increased body weight на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Increased body weight after menopause.
Currently, everyone knows about the dangers of increased body weight.
Increased body weight, poor diet and lack of exercise;
That is why,if you notice that your child has increased body weight, then you should immediately take up your child.
Increased body weight is most often associated with excessive food intake and significantly reduced motor activity.
Varicose veins may be observed,especially if you have a second pregnancy, increased body weight, or a genetic predisposition.
Hormone changes and increased body weight can cause joint pain for many pregnant women, especially lower back pain.
Based on a population PK analysis, sotagliflozin exposure was found to decrease with increased body weight.
During the period of active bone growth and increased body weight for children it is important to provide a correct and balanced diet.
Increased body weight and obesity are known to contribute to an array of health complications, including type 2 diabetes and hypertension.
Characterized by: intolerance to low ambient temperatures, increased body weight, hair loss, the appearance of early gray hair.
The many positive testimonies found in internet for this product confirm its effective ability against fat and increased body weight.
But, most of the people using this report bulking effects and increased body weight because of its role as an appetite stimulant.
In particular, limited but inconclusive data suggest that there may be reduced efficacy of these medicinal products with increased body weight in women.
Such action may be asymptomatic or manifest as headache, dizziness, seizures, nausea, vomiting, dry mouth,peripheral edema and increased body weight.
Several studies found very much underestimating calories consumed by people with increased body weight and obesity, as well as older people who tend to underestimate it.
I am a nutritionist, I have to constantly monitor the list of new drugsfor weight loss in order to use it in a comprehensive program for women with increased body weight.
Increased body weight can significantly increase the risk of developing sleep apnea- a condition in which the patient while sleeping stops breathing for several seconds to one minute.
The data are currently too limited andtherefore insufficiently precise to draw definite conclusions whether efficacy is negatively influenced by increased body weight and BMI.
Increased body weight associated with increased blood cholesterol, high blood pressure and reducing the level of HDL(good cholesterol) and physical activity.
Baseline factors associated with development ofgenotypic drug resistance included: lamivudine treatment, higher baseline HBV DNA, lower baseline serum ALT, and increased body weight/ BMI.
Also, if the doctor sees increased skin greasiness,obesity or increased body weight, the manifestation of hyperandrogenism, it will not even be long to think whether you need to take hormones.
For UPA-containing emergency contraceptive products(ellaOne)it is concluded that limited and inconclusive data suggest that there may be reduced efficacy of UPA with increased body weight in women.
The data arecurrently too limited and therefore insufficiently precise to draw definite conclusions whether efficacy is negatively influenced by increased body weight and BMI; for instance for the obese category(BMI≥30) three pregnancies were reported in the first analysis, and eleven pregnancies in the second.
A population pharmacokinetic analysis including data from subjects and patients demonstrated that regadenoson clearance decreases in parallel with a reduction in creatinine clearance(CLcr)and increases with increased body weight.
Analysis of plasma concentration data from patients in clinical trials indicated that the clearance of enfuvirtide is 20% lower in females than males irrespective of weight andis increased with increased body weight irrespective of gender(20% higher in a 100 kg and 20% lower in a 40 kg body weight patient relative to a 70 kg reference patient).
Present data from PK/PD/efficacy modelling from the RESTORE study which indicates that risk of return of MS disease activity more likely with increased body weight(> 80kg) or longer dosing intervals(> 7 weeks).
Analysis of plasma concentration data from patients in clinical trials indicated that the clearance of enfuvirtide is 20% lower in females than males irrespective of weight andis increased with increased body weight irrespective of gender(20% higher in a 100 kg and 20% lower in a 40 kg body weight patient relative to a 70 kg reference patient).